{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,23]],"date-time":"2026-07-23T05:14:24Z","timestamp":1784783664932,"version":"3.55.0"},"reference-count":33,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,7,6]],"date-time":"2021-07-06T00:00:00Z","timestamp":1625529600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2021,7,6]],"date-time":"2021-07-06T00:00:00Z","timestamp":1625529600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Med-Life Discoveries"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Orphanet J Rare Dis"],"published-print":{"date-parts":[[2021,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Rhizomelic chondrodysplasia punctata (RCDP) is an inherited ultra-rare disease which results in severely impaired physical and mental development. Mutations in one of five genes involved in plasmalogen biosynthesis have been reported to drive disease pathology. Estimates of disease incidence have been extremely challenging due to the rarity of the disorder, preventing an understanding of the unmet medical need. To address this, we have prepared a disease incidence and prevalence model based on genetic epidemiology approaches to estimate the total number of RCDP patients affected, and their demographic characteristics.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>Extraction of allelic frequencies for known and predicted pathogenic variants in <jats:italic>PEX7, GNPAT, AGPS, FAR1, PEX5<\/jats:italic> (limited to the PTS2 domain encoding region) genes, from large-scale human genetic diversity datasets (TopMed and gnomAD) revealed the mutational landscape contributing to the RCDP patient population in the US and Europe. We computed genetic prevalence to derive birth incidence for RCDP and modeled the impact to life expectancy to obtain high confidence estimates of disease prevalence. Our population genetics-based model indicates PEX7 variants are expected to contribute to the majority of RCDP cases in both the US and Europe; closely aligning with clinical reports. Furthermore, this model provides estimates for RCDP subtypes due to mutations in other genes, including exceedingly rare subtypes.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusion<\/jats:title>\n                <jats:p>In total, the estimated number of RCDP patients in the US and the five largest European countries (UK, Germany, France, Italy and Spain) is between 516 and 847 patients, all under the age of 35\u00a0years old. This model provides a quantitative framework for better understanding the unmet medical need in RCDP, to help guide disease awareness and diagnosis efforts for this specific patient group.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s13023-021-01889-z","type":"journal-article","created":{"date-parts":[[2021,7,6]],"date-time":"2021-07-06T08:02:46Z","timestamp":1625558566000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":15,"title":["Genetic epidemiology approach to estimating birth incidence and current disease prevalence for rhizomelic chondrodysplasia punctata"],"prefix":"10.1186","volume":"16","author":[{"given":"Tarik","family":"Luisman","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tara","family":"Smith","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shawn","family":"Ritchie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8120-2971","authenticated-orcid":false,"given":"Karen E.","family":"Malone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,7,6]]},"reference":[{"key":"1889_CR1","doi-asserted-by":"publisher","first-page":"332","DOI":"10.1002\/ajmg.a.20009","volume":"118 A","author":"AL White","year":"2003","unstructured":"White AL, Modaff P, Holland-Morris F, Pauli RM. Natural history of rhizomelic chondrodysplasia punctata. Am J Med Genet. 2003;118 A:332\u201342.","journal-title":"Am J Med Genet"},{"key":"1889_CR2","doi-asserted-by":"publisher","first-page":"579","DOI":"10.1002\/ajmg.a.61413","volume":"182","author":"AL Duker","year":"2020","unstructured":"Duker AL, et al. Rhizomelic chondrodysplasia punctata morbidity and mortality, an update. Am J Med Genet A. 2020;182:579\u201383.","journal-title":"Am J Med Genet A"},{"key":"1889_CR3","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1038\/ng0497-381","volume":"15","author":"PE Purdue","year":"1997","unstructured":"Purdue PE, Zhang JW, Skoneczny M, Lazarow PB. Rhizomelic chondrodysplasia punctata is caused by deficiency of human PEX7, a homologue of the yeast PTS2 receptor. Nat Genet. 1997;15:381\u20134.","journal-title":"Nat Genet"},{"key":"1889_CR4","doi-asserted-by":"publisher","first-page":"612","DOI":"10.1086\/338998","volume":"70","author":"AM Motley","year":"2002","unstructured":"Motley AM, et al. Mutational spectrum in the PEX7 gene and functional analysis of mutant alleles in 78 patients with rhizomelic chondrodysplasia punctata type 1. Am J Hum Genet. 2002;70:612\u201324.","journal-title":"Am J Hum Genet"},{"key":"1889_CR5","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1038\/ng0497-369","volume":"15","author":"N Braverman","year":"1997","unstructured":"Braverman N, et al. Human PEX7 encodes the peroxisomal PTS2 receptor and is responsible for rhizomelic chondrodysplasia punctata. Nat Genet. 1997;15:369\u201376.","journal-title":"Nat Genet"},{"key":"1889_CR6","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1002\/humu.10124","volume":"20","author":"N Braverman","year":"2002","unstructured":"Braverman N, et al. Mutation analysis of PEX7 in 60 probands with rhizomelic chondrodysplasia punctata and functional correlations of genotype with phenotype. Hum Mutat. 2002;20:284\u201397.","journal-title":"Hum Mutat"},{"key":"1889_CR7","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1038\/ng0497-377","volume":"15","author":"AM Motley","year":"1997","unstructured":"Motley AM, et al. Rhizomelic chondrodysplasia punctata is a peroxisomal protein targeting disease caused by a non-functional PTS2 receptor. Nat Genet. 1997;15:377\u201380.","journal-title":"Nat Genet"},{"key":"1889_CR8","doi-asserted-by":"publisher","first-page":"602","DOI":"10.1016\/j.ajhg.2014.10.003","volume":"95","author":"R Buchert","year":"2014","unstructured":"Buchert R, et al. A peroxisomal disorder of severe intellectual disability, epilepsy, and cataracts due to fatty acyl-CoA reductase 1 deficiency. Am J Hum Genet. 2014;95:602\u201310.","journal-title":"Am J Hum Genet"},{"key":"1889_CR9","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1007\/BF02435984","volume":"15","author":"RJA Wanders","year":"1992","unstructured":"Wanders RJA, Schumacher H, Heikoop J, Schutgens RBH, Tager JM. Human dihydroxyacetonephosphate acyltransferase deficiency: a new peroxisomal disorder. J Inher Metab Dis. 1992;15:389\u201391.","journal-title":"J Inher Metab Dis"},{"key":"1889_CR10","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1007\/BF00711817","volume":"17","author":"RJA Wanders","year":"1994","unstructured":"Wanders RJA, et al. Human alkyldihydroxyacetonephosphate synthase deficiency: a new peroxisomal disorder. J Inher Metab Dis. 1994;17:315\u20138.","journal-title":"J Inher Metab Dis"},{"key":"1889_CR11","doi-asserted-by":"publisher","first-page":"5845","DOI":"10.1093\/hmg\/ddv305","volume":"24","author":"T Bar\u00f8y","year":"2015","unstructured":"Bar\u00f8y T, et al. A novel type of rhizomelic chondrodysplasia punctata, RCDP5, is caused by loss of the PEX5 long isoform. Hum Mol Genet. 2015;24:5845\u201354.","journal-title":"Hum Mol Genet"},{"key":"1889_CR12","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1186\/1750-1172-8-174","volume":"8","author":"AM Bams-Mengerink","year":"2013","unstructured":"Bams-Mengerink AM, Koelman JHTM, Waterham H, Barth PG, Poll-The BT. The neurology of rhizomelic chondrodysplasia punctata. Orphanet J Rare Dis. 2013;8:174.","journal-title":"Orphanet J Rare Dis"},{"key":"1889_CR13","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1002\/ajmg.a.37961","volume":"173","author":"AL Duker","year":"2017","unstructured":"Duker AL, et al. Growth charts for individuals with rhizomelic chondrodysplasia punctata. Am J Med Genet A. 2017;173:108\u201313.","journal-title":"Am J Med Genet A"},{"key":"1889_CR14","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1002\/humu.21623","volume":"33","author":"B Itzkovitz","year":"2012","unstructured":"Itzkovitz B, et al. Functional characterization of novel mutations in GNPAT and AGPS, causing rhizomelic chondrodysplasia punctata (RCDP) types 2 and 3. Hum Mutat. 2012;33:189\u201397.","journal-title":"Hum Mutat"},{"key":"1889_CR15","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1111\/j.1399-0004.1989.tb02912.x","volume":"35","author":"C Stoll","year":"1989","unstructured":"Stoll C, Dott B, Roth M-P, Alembik Y. Birth prevalence rates of skeletal dysplasias. Clin Genet. 1989;35:88\u201392.","journal-title":"Clin Genet"},{"key":"1889_CR16","doi-asserted-by":"publisher","first-page":"e0155552","DOI":"10.1371\/journal.pone.0155552","volume":"11","author":"K Fujikura","year":"2016","unstructured":"Fujikura K. Global carrier rates of rare inherited disorders using population exome sequences. PLoS ONE. 2016;11:e0155552.","journal-title":"PLoS ONE"},{"key":"1889_CR17","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1038\/gim.2012.114","volume":"15","author":"GA Lazarin","year":"2013","unstructured":"Lazarin GA, et al. An empirical estimate of carrier frequencies for 400+ causal Mendelian variants: results from an ethnically diverse clinical sample of 23,453 individuals. Genet Med. 2013;15:178\u201386.","journal-title":"Genet Med"},{"key":"1889_CR18","doi-asserted-by":"publisher","first-page":"933","DOI":"10.2147\/CCID.S232547","volume":"12","author":"S Eichstadt","year":"2019","unstructured":"Eichstadt S, et al. From clinical phenotype to genotypic modelling: incidence and prevalence of recessive dystrophic epidermolysis bullosa (RDEB). Clin Cosmet Investig Dermatol. 2019;12:933\u201342.","journal-title":"Clin Cosmet Investig Dermatol"},{"key":"1889_CR19","doi-asserted-by":"publisher","first-page":"2710","DOI":"10.1073\/pnas.1913179117","volume":"117","author":"M Hanany","year":"2020","unstructured":"Hanany M, Rivolta C, Sharon D. Worldwide carrier frequency and genetic prevalence of autosomal recessive inherited retinal diseases. Proc Natl Acad Sci USA. 2020;117:2710\u20136.","journal-title":"Proc Natl Acad Sci USA"},{"key":"1889_CR20","doi-asserted-by":"publisher","first-page":"1250","DOI":"10.1002\/jcb.22979","volume":"112","author":"PK Dranchak","year":"2011","unstructured":"Dranchak PK, et al. Nonsense suppressor therapies rescue peroxisome lipid metabolism and assembly in cells from patients with specific PEX gene mutations. J Cell Biochem. 2011;112:1250\u20138.","journal-title":"J Cell Biochem"},{"key":"1889_CR21","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1006\/geno.1999.6080","volume":"63","author":"N Braverman","year":"2000","unstructured":"Braverman N, et al. PEX7 gene structure, alternative transcripts, and evidence for a founder haplotype for the frequent RCDP allele, L292ter. Genomics. 2000;63:181\u201392.","journal-title":"Genomics"},{"key":"1889_CR22","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1002\/jimd.12349","volume":"123","author":"W Fallatah","year":"2020","unstructured":"Fallatah W, et al. Clinical, biochemical and molecular characterization of mild (nonclassic) Rhizomelic Chondrodysplasia Punctata. J Inherit Metab Dis. 2020;123:49. https:\/\/doi.org\/10.1002\/jimd.12349.","journal-title":"J Inherit Metab Dis"},{"key":"1889_CR23","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1016\/j.cell.2018.12.015","volume":"176","author":"A Kishore Jaganathan","year":"2018","unstructured":"Kishore Jaganathan A, et al. Predicting Splicing from Primary Sequence with Deep Learning In Brief A deep neural network precisely models mRNA splicing from a genomic sequence and accurately predicts noncoding cryptic splice mutations in patients with rare genetic diseases. Predicting Splicing from Primary Sequence with Deep Learning. Cell. 2018;176:535\u201348.","journal-title":"Cell"},{"key":"1889_CR24","doi-asserted-by":"publisher","first-page":"698","DOI":"10.1212\/01.wnl.0000255960.01644.39","volume":"68","author":"MA Horn","year":"2007","unstructured":"Horn MA, et al. Phenotype of adult Refsum disease due to a defect in peroxin 7. Neurology. 2007;68:698\u2013700.","journal-title":"Neurology"},{"key":"1889_CR25","doi-asserted-by":"publisher","first-page":"471","DOI":"10.1086\/346093","volume":"72","author":"DM van den Brink","year":"2003","unstructured":"van den Brink DM, et al. Identification of PEX7 as the second gene involved in Refsum disease. Am J Hum Genet. 2003;72:471\u20137.","journal-title":"Am J Hum Genet"},{"key":"1889_CR26","doi-asserted-by":"publisher","first-page":"847","DOI":"10.1093\/hmg\/7.5.847","volume":"7","author":"R Ofman","year":"1998","unstructured":"Ofman R, et al. Acyl-CoA: Dihydroxyacetonephosphate acyltransferase: cloning of the human cDNA and resolution of the molecular basis in rhizomelic chondrodysplasia punctata type 2. Hum Mol Genet. 1998;7:847\u201353.","journal-title":"Hum Mol Genet"},{"key":"1889_CR27","first-page":"563866","volume":"2","author":"D Taliun","year":"2019","unstructured":"Taliun D, et al. Sequencing of 53,831 diverse genomes from the NHLBI TOPMed Program. bioRxiv. 2019;2:563866.","journal-title":"bioRxiv"},{"key":"1889_CR28","unstructured":"The NHLBI Trans-Omics for Precision Medicine (TOPMed) Whole Genome Sequencing Program. BRAVO variant browser: University of Michigan and NHLBI. https:\/\/bravo.sph.umich.edu\/freeze5\/hg38\/ (2018)."},{"key":"1889_CR29","doi-asserted-by":"publisher","first-page":"444","DOI":"10.1038\/s41586-020-2287-8","volume":"581","author":"RL Collins","year":"2020","unstructured":"Collins RL, et al. A structural variation reference for medical and population genetics. Nature. 2020;581:444\u201351.","journal-title":"Nature"},{"key":"1889_CR30","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1186\/s13059-016-0974-4","volume":"17","author":"W McLaren","year":"2016","unstructured":"McLaren W, et al. The ensembl variant effect predictor. Genome Biol. 2016;17:122.","journal-title":"Genome Biol"},{"key":"1889_CR31","first-page":"119","volume":"52","author":"A Agresti","year":"1998","unstructured":"Agresti A, Coull BA. Approximate is better than \u201cexact\u201d for interval estimation of binomial proportions. Am Stat. 1998;52:119.","journal-title":"Am Stat"},{"key":"1889_CR32","unstructured":"Federal Reserve Economic Data|FRED|St. Louis Fed. https:\/\/fred.stlouisfed.org\/."},{"key":"1889_CR33","unstructured":"Home\u2014Eurostat. https:\/\/ec.europa.eu\/eurostat."}],"container-title":["Orphanet Journal of Rare Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13023-021-01889-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13023-021-01889-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13023-021-01889-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,7,6]],"date-time":"2021-07-06T08:07:16Z","timestamp":1625558836000},"score":1,"resource":{"primary":{"URL":"https:\/\/ojrd.biomedcentral.com\/articles\/10.1186\/s13023-021-01889-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,7,6]]},"references-count":33,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,12]]}},"alternative-id":["1889"],"URL":"https:\/\/doi.org\/10.1186\/s13023-021-01889-z","relation":{},"ISSN":["1750-1172"],"issn-type":[{"value":"1750-1172","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,7,6]]},"assertion":[{"value":"5 February 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 May 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 July 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable, as no individual human data is utilized in this model.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"TL and KM are employed by Leiden Analytics. SR and TS are employed by Med-Life Discoveries.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"300"}}